<DOC>
	<DOCNO>NCT00228904</DOCNO>
	<brief_summary>Diabetic neuropathy progressive complication cause serious problem 25-40 % diabetic patient . Anecdotal report indicate improvement pulsatile IV insulin therapy affect patient otherwise resistant conventional therapy . Significant complication produce painful peripheral dysesthesias , loss sensation gastroparesis . This study design test effectiveness pulsatile IV insulin therapy diabetic neuropathy .</brief_summary>
	<brief_title>Effects Pulsatile Intravenous Insulin Delivery Diabetic Neuropathy pATIENTS ( Pts ) With Type 1 Type 2 Diabetes</brief_title>
	<detailed_description>Diabetic neuropathy ( DN ) progressive complication cause serious problem 25 % -40 % diabetic patient . Significant complication produce painful peripheral dysesthesias , loss sensation , gastroparesis . DN may affect peripheral motor sensory nerve addition autonomic nervous system ( 1-3 ) . Treatment strategy patient DN generally concentrate pain relief , without address underlie pathophysiology disease ( 4 ) . Anecdotal report patient treat pulsatile IV insulin therapy complication suggest treatment may show efficacy patient DN . This study design compare patient DN receive pulsatile IV insulin therapy control group . Pulsatile IV insulin therapy encourage glucose metabolism diabetic normalize multiple organ , especially muscle , retina , liver , kidney nerve ending . The process fundamentally require administration high dose insulin pulse similar secrete non diabetic human pancreas surround portal circulation . Oral carbohydrate give simultaneously augment process prevent hypoglycemia . The process monitor frequent measure glucose level respiratory quotient ( RQ ) . RQ measure metabolic cart determines ratio VCO2/VO2 . This ratio specific fuel use one time body . The glucose level monitor keep glucose level appropriate RQ determines need readjust infusion protocol patient subsequent insulin infusion session . Pulsatile IV insulin therapy do 1-hour period 1-hour rest period treatment . Three treatment give patient visit center . Frequent monitoring RQ necessary level change rapidly , depend fuel utilize body . IV insulin give pulse shift metabolism primarily fatty acid metabolism primarily glucose metabolism . This shift reflect increase respiratory quotient . However rest period RQ may fall back low level . Therefore RQs do begin end insulin infusion session order appropriately monitor adjust insulin carbohydrate load reach optimal activation session . The respiratory quotient ( RQ ) measurement CO2 exhale O2 inhale proportionate fuel source use body , primarily liver short period time . The high RQ , glucose less alternative fuel source utilize . Following RQ change help determine effectiveness physiological insulin administration increase anabolic function diabetic individual . By improve body 's glucose metabolism thereby cause beneficial effect anabolic factor , possibility serious complication decrease . In addition use oral carbohydrate time along physiologic insulin administration stimulate appropriate gut hormone augment effect , response duplicate intravenous glucose . The purpose study determine whether physiologic administration insulin along augment effect oral carbohydrate normalize metabolism diabetic patient correlate improvement manifestation diabetic neuropathy . The RQ determine use metabolic cart . Individuals breathe mask 3-5 minute rest period 30 minute . The ratio exhale volume CO2 inhale volume O2 determine RQ . The physiologic range 0.7 1.3 . Individuals use fat primary fuel ratio 0.7 , protein mixed fuel 0.8-0.9 carbohydrate 0.9-1.0 . Those take excessive calorie RQs high 1.05 . The amount intravenous insulin oral glucose give determine RQ change previous session . 1 . Tesfaye S , Chaturvedi N , Eaton SEM , Ward JD , Manes C , Ionescu-Tirgoviste C , witte DR , Fuller JH , Vascular Risk factor Diabetic Neuropathy N Engl J Med 352:341-50 , 2005 . 2 . Neuropathy Trust , Diabetic Neuropathy : Prevalence , www.neurocentre.com . 3 . Potter PJ , Maryniak O , Yamorski R , Jones IC , Incidence Peripheral Neuropathy Contralateral Limb Persons Unilateral Amputation due Diabetes , Journal Rehabilitation Research Development 35:335-39 , 1998 . 4 . Goldstein DJ , Lu Y , Detke MJ , Lee TC , Iyengan , Duloxetine versus Placebo Patients Painful Diabetic Neuropathy , Pain 116:109-18 , 2005 .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Up 500 patient male female age 20 90 diagnose type 1 type 2 diabetes mellitus . All patient diagnose endocrinologist diabetic neuropathy . All patient fail conventional treatment diabetic neuropathy . All patient take oral agent and/or insulin diabetic control . All patient endocrinologist 's supervision diabetes management . Endocrinologist must assess approve patient participation study . All patient must demonstrate ability swallow without difficulty ability commit weekly time requirement associate study . Other cause complication related diabetes Lack intravenous access Pregnancy Alcohol abuse , drug addiction use illegal drug HIV positive Inability breathe machine respiratory quotient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pulsatile intravenous insulin</keyword>
	<keyword>Oral carbohydrate loading</keyword>
	<keyword>Respiratory Quotients</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Diabetic Neuropathy</keyword>
	<keyword>Diabetes Mellitus , complication</keyword>
</DOC>